Mechanistic characterization of SARS-CoV2 associated kidney injury
SARS-CoV2相关肾损伤的机制特征
基本信息
- 批准号:10427448
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-11 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAcuteAcute Renal Failure with Renal Papillary NecrosisAcute Respiratory Distress SyndromeAgeApoptosisCOVID-19COVID-19 complicationsCOVID-19 patientCRISPR screenCaspaseCell DeathCellsCessation of lifeClinical ResearchClustered Regularly Interspaced Short Palindromic RepeatsCoculture TechniquesCohort AnalysisComplexCoronavirusDataDiseaseEtiologyFunctional disorderGenesGoalsHMGB1 geneHistopathologyHumanISG15 geneIn VitroIndividualInfectionInflammationInflammatoryInflammatory ResponseInjuryInjury to KidneyIntegration Host FactorsInterferonsK-18 conjugateKidneyKnockout MiceLungMapsMediatingModelingMolecularMusOrganOrganoidsPathogenesisPathway interactionsPatientsPatternPersonsPlayPredispositionProductionProtein KinaseProteinsPulmonary InflammationRIPK1 geneRegulationReperfusion InjuryReportingRisk FactorsRoleSARS coronavirusSARS-CoV-2 infectionSARS-CoV-2 pathogenesisSerumSeverity of illnessSourceSystemTestingTherapeuticTracheal EpitheliumTransgenic MiceTropismTubular formationUbiquitin Like ProteinsUnited StatesViralViral Load resultViral ProteinsVirusVirus DiseasesWorkbasecell injurychemokinecytokinecytokine release syndromeeffective interventiongenome-widehuman coronavirusin vivoinduced pluripotent stem cellinsightkidney cellkidney epithelial cellmortality riskmouse modelnovelrenal damageresponsesevere COVID-19systemic inflammatory responsetherapeutic development
项目摘要
SARS-CoV2 is a highly contagious, novel human coronavirus that causes coronavirus disease 2019 (COVID-
19). Currently over 16.5 million people in the US have confirmed infection with SARS-CoV2 and over 300,000
have died. Severe COVID-19 is characterized by pulmonary and systemic inflammation and multi-organ
dysfunction, with a significant portion of severe COVID patients developing acute kidney injury. The mechanism
by which SARS-CoV2 triggers such severe pathogenesis is poorly understood. Recent clinical studies have
suggested that cell death, especially the induction of necroptosis, may be a predictor of severe COVID-19
disease. The mechanism by which the host restricts necroptosis is unclear. In preliminary data we have shown
that the interferon induced protein, ISG15, acts as a negative regulator of necroptosis and its downstream
inflammatory responses during viral infection. We have also shown that ISG15 deficient mice rapidly succumb
to ischemia-reperfusion injury of the kidney characterized by a massive release of proinflammatory cytokines.
In this proposal we will test the hypothesis that ISG15 serves as a critical host restriction factor in regulating
programmed necroptosis and downstream inflammatory responses within the kidney to limit acute kidney injury
during SARS-CoV2 infection. We will utilize kidney organoids derived from induce pluripotent stem cells in which
ISG15 has been deleted by CRISPR, a co-culture system with kidney organoids and primary tracheal epithelial
cultures (hTECs), and in vivo mouse model of SARS-CoV-2 to ask several questions including: 1) Does SARS-
CoV2 induce damage to kidney epithelial cells via direct viral transduction or in response to systemic
inflammation?; 2) Does ISG15 modulate necroptotic cell death as well as proinflammatory cytokine/chemokine
production in kidney epithelial cells during SARS-CoV2 infection?; 3) Does necroptosis and its regulation by
ISG15 contribute to acute kidney injury during SARS-CoV2 infection? Overall, our studies will provide important
insight into host factors that restrict necroptosis and could be an important contributor to severe COVID-19
induced kidney injury.
SARS-CoV 2是一种高度传染性的新型人类冠状病毒,可导致2019年冠状病毒病(COVID-19)。
19)。目前,美国有超过1650万人确认感染了SARS-CoV 2,
都死了重症COVID-19的特征是肺部和全身炎症以及多器官
严重的COVID患者中有很大一部分发生急性肾损伤。机制
SARS-CoV 2是如何引发这种严重的发病机制尚不清楚。最近的临床研究
表明细胞死亡,特别是诱导坏死性凋亡,可能是严重COVID-19的预测因子
疾病宿主限制坏死性凋亡的机制尚不清楚。初步数据显示,
干扰素诱导蛋白ISG 15作为坏死性凋亡的负调节因子,
病毒感染时的炎症反应。我们还表明,ISG 15缺陷小鼠迅速死亡,
以大量释放促炎细胞因子为特征的肾缺血-再灌注损伤。
在本提案中,我们将检验ISG 15作为调节细胞凋亡的关键宿主限制因子的假设。
肾脏内程序性坏死性凋亡和下游炎症反应,以限制急性肾损伤
在SARS-CoV 2感染期间。我们将利用来源于诱导多能干细胞的肾类器官,
ISG 15已被CRISPR删除,CRISPR是一种与肾类器官和原代气管上皮共培养系统
培养物(hTECs)和SARS-CoV-2的体内小鼠模型,以提出几个问题,包括:1)SARS-
CoV 2通过直接病毒转导或响应系统性免疫应答诱导肾上皮细胞损伤。
炎症?2)ISG 15是否调节坏死性细胞死亡以及促炎细胞因子/趋化因子
SARS-CoV 2感染过程中肾脏上皮细胞的产生?3)坏死性凋亡及其调节是否
ISG 15与SARS-CoV 2感染时急性肾损伤有关?总的来说,我们的研究将提供重要的
深入了解限制坏死性凋亡的宿主因素,可能是严重COVID-19的重要因素
导致肾损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah J Lenschow其他文献
Deborah J Lenschow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah J Lenschow', 18)}}的其他基金
Mechanistic characterization of SARS-CoV2 associated kidney injury
SARS-CoV2相关肾损伤的机制特征
- 批准号:
10319713 - 财政年份:2021
- 资助金额:
$ 39.38万 - 项目类别:
Mechanistic characterization of SARS-CoV2 associated kidney injury
SARS-CoV2相关肾损伤的机制特征
- 批准号:
10619568 - 财政年份:2021
- 资助金额:
$ 39.38万 - 项目类别:
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
SARS-CoV2 感染期间 ISG15 对细胞死亡和炎症的调节
- 批准号:
10287787 - 财政年份:2021
- 资助金额:
$ 39.38万 - 项目类别:
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
SARS-CoV2 感染期间 ISG15 对细胞死亡和炎症的调节
- 批准号:
10424558 - 财政年份:2021
- 资助金额:
$ 39.38万 - 项目类别:
Washington University Rheumatic DiseasesResearch Resource-based Center
华盛顿大学风湿病研究资源中心
- 批准号:
10472003 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
Washington University Rheumatic DiseasesResearch Resource-based Center
华盛顿大学风湿病研究资源中心
- 批准号:
9764270 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
Washington University Rheumatic DiseasesResearch Resource-based Center
华盛顿大学风湿病研究资源中心
- 批准号:
10019327 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
Washington University Rheumatic DiseasesResearch Resource-based Center
华盛顿大学风湿病研究资源中心
- 批准号:
10251236 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
Washington University Rheumatic Diseases Research Resource-based Center
华盛顿大学风湿病研究资源中心
- 批准号:
10704273 - 财政年份:2018
- 资助金额:
$ 39.38万 - 项目类别:
REGULATION OF INFLUENZA VIRUS INFECTION BY ISG15
ISG15 对流感病毒感染的监管
- 批准号:
8109260 - 财政年份:2009
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Operating Grants